LUCAT1 and renal carcinoma: The ROC curve suggested that the risk assessment model constructed by those 5 FR-DELs (DOCK8-AS1, SNHG17, RUSC1-AS1, LINC02609, and LUCAT1) could be used for prognosis signatures for renal cancer patients.